Year: 2003
Type: article
Abstract: Long-term survival of kidney transplants (renal allografts) has changed little during the past decade, despite dramatic improvements in short-term survival. Most late renal allograft loss, other than that associated with the death of the patient, has been attributed to progressive renal dysfunction, termed “chronic allograft nephropathy” (or CAN), a confusing term that lacks a rigorous consensus definition.Chronic allograft nephropathy entered prime time in 1993 as a category in the Banff diseases of kidney-transplant diseases that included at least four entities that could not always be differentiated on biopsy (chronic rejection, chronic toxic effects of cyclosporine; hypertensive vascular disease; and . . .
Source: New England Journal of Medicine
DOI: 10.1056/nejmp038178
Author: Robert B. Colvin
Institution: Massachusetts General Hospital
Language: English
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4248853684